Andrew Morton

ORCID: 0000-0001-9432-9509
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Urologic and reproductive health conditions
  • Hemodynamic Monitoring and Therapy
  • Respiratory Support and Mechanisms
  • Cardiac, Anesthesia and Surgical Outcomes
  • Advanced Statistical Process Monitoring
  • Bladder and Urothelial Cancer Treatments
  • Urological Disorders and Treatments
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Cancer, Lipids, and Metabolism
  • Radiomics and Machine Learning in Medical Imaging
  • Airway Management and Intubation Techniques
  • Urinary and Genital Oncology Studies
  • Electrical and Bioimpedance Tomography
  • Antimicrobial Resistance in Staphylococcus
  • Abdominal Surgery and Complications
  • Healthcare Policy and Management
  • Healthcare Operations and Scheduling Optimization
  • Intraocular Surgery and Lenses
  • Surgical site infection prevention
  • Radiopharmaceutical Chemistry and Applications
  • Non-Invasive Vital Sign Monitoring
  • Pelvic floor disorders treatments
  • Pulmonary Hypertension Research and Treatments

The University of Queensland
1978-2024

Ipswich Hospital
2022-2024

Royal Brisbane and Women's Hospital
2019-2023

Queensland University of Technology
1990-2010

Princess Alexandra Hospital
2002-2010

Defence Research and Development Canada
2002-2003

Princess Alexandra Hospital
2001

Manchester Royal Infirmary
1999

Repatriation General Hospital
1969-1989

Greenslopes Private Hospital
1983-1989

Different nomograms exist for the preoperative prediction of pelvic lymph-node metastatic disease in individual patients with prostate cancer (PCa). These do not incorporate modern imaging techniques such as prostate-specific membrane antigen (PSMA) positron emission tomography (PET).To determine predictive performance Briganti 2017, Memorial Sloan Kettering Cancer Center (MSKCC), and 2019 addition PSMA-PET an international, multicenter, present-day cohort undergoing robot-assisted radical...

10.1016/j.eururo.2021.05.006 article EN cc-by European Urology 2021-05-21

The prognostic value of PSMA intensity on PET/CT due to underlying biology and subsequent clinical implications is an emerging topic interest. We sought investigate whether primary tumour PET contributes pre- post-operative prediction oncological outcomes following radical prostatectomy.We performed a retrospective cohort study 848 men who underwent all multiparametric MRI (mpMRI), transperineal prostate biopsy, 68 Ga-PSMA prior prostatectomy. intensity, quantified as maximum standard uptake...

10.1007/s00259-022-05756-2 article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2022-03-17

Objective To examine national trends in the medical and surgical treatment of benign prostatic hyperplasia (BPH) using Australian Medicare Benefits Schedule (MBS) Pharmaceutical Scheme (PBS) population data from 2000 to 2018. Patients methods Annual was extracted MBS, PBS Institute Health Welfare databases for years 2000–2018. Population‐adjusted rates BPH procedures therapies were calculated compared relation age. Cost analysis performed estimate financial burden due BPH. Results Overall...

10.1111/bju.15098 article EN BJU International 2020-06-17

Objectives To construct and externally calibrate a predictive model for early biochemical recurrence (BCR) after radical prostatectomy (RP) incorporating clinical modern imaging characteristics of the primary tumour. Patients Methods who underwent RP following multiparametric magnetic resonance imaging, prostate biopsy prostate‐specific membrane antigen‐positron emission tomography/computed tomography (PSMA‐PET/CT), from two centres in Australia Netherlands. The outcome was recurrence‐free...

10.1111/bju.16482 article EN cc-by-nc-nd BJU International 2024-09-11

This paper describes a method for creating confidence interval the ratio of rates using score statistic. non-iterative and easy to apply procedure produces intervals that are suitable use with Poisson data simulation results indicate it is close nominal level wide range scenarios.

10.1002/sim.1405 article EN Statistics in Medicine 2003-03-18

This study aimed to describe perioperative, oncological and learning curve outcomes for robotic-assisted radical cystectomy (RARC) across the first 100 cases performed by an Australian high-volume, fellowship-trained robotic surgeon.A retrospective cohort was on a consecutive group of patients who underwent RARC between 2010 2016 in Brisbane, Australia. Perioperative, survival data were collected. Demographic, analyses MedCalc.A total over period. Median operative time 389 min, with...

10.1111/ans.15413 article EN ANZ Journal of Surgery 2019-09-02

This report describes a boy in his early adolescence who was referred to urologist with large, painless right scrotal mass. Following thorough workup, the patient underwent surgical removal of mass, which revealed be paratesticular fibrous pseudotumour (PFP) on histopathological analysis. diagnosis is rare and can often prove difficult distinguish from malignant lesion within scrotum. We have conducted review current literature surrounding PFP compliment case discussion.

10.1136/bcr-2024-260376 article EN BMJ Case Reports 2024-07-01

To evaluate methods for monitoring monthly aggregated hospital adverse event data that display clustering, non-linear trends and possible autocorrelation.Retrospective audit.The Northern Hospital, Melbourne, Australia.171,059 patients admitted between January 2001 December 2006.The analysis is illustrated with 72 months of patient fall injury using a modified Shewhart U control chart, charts derived from quasi-Poisson generalised linear model (GLM) additive mixed (GAMM) included an...

10.1136/qshc.2007.025601 article EN BMJ Quality & Safety 2009-12-01
Coming Soon ...